Concepedia

Andreas Feichtner

AF

Statistics

Publications

5

Citations

206

H-Index

5

Active since

2019

Affiliations

Universität Innsbruck(Current)

Agency for Science, Technology and Research

Bioinformatics Institute

Tyrolean Cancer Research Institute

Innsbruck Medical University

Andreas Feichtner is an author at Universität Innsbruck specializing in oncology, signal transduction, and kinase inhibitors.

ORCID

Publications per year

2019–2023

5

Publications

5

mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif

Timothy R. Baffi, Gema Lordén, Jacob M. Wozniak et al. · Science Signaling · 2021 · 111 citations · Full text

, , +7

BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS

Ruth Röck, Johanna E. Mayrhofer, Omar Torres‐Quesada et al. · Science Advances · 2019 · 46 citations · Full text

, , +17

Mutation-oriented profiling of autoinhibitory kinase conformations predicts RAF inhibitor efficacies

Johanna E. Mayrhofer, Florian Enzler, Andreas Feichtner et al. · Proceedings of the National Academy of Sciences · 2020 · 24 citations · Full text

, , +15

Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico

Jakob Fleischmann, Andreas Feichtner, Louis DeFalco et al. · Biomolecules · 2021 · 14 citations · Full text

, , +16

Missense variant interaction scanning reveals a critical role of the FERM domain for tumor suppressor protein NF2 conformation and function

Christina S. Moesslacher, Elisabeth Auernig, Jonathan Woodsmith et al. · Life Science Alliance · 2023 · 11 citations · Full text

, , +9

1–5 of 5